Nektar TherapeuticsNKTRNASDAQ
LOADING
|||
Analyst Sentiment
Analysts lean bullish — 69% recommend buying.
Consensus Rating
Buy
32 analysts·High coverage
69%
Rating Distribution
Strong Buy
00%
Buy
2269%
Hold
516%
Sell
516%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Analysts see significant upside — consensus target 219% higher.
Bear Case
$105.00
+181%
Consensus
$119.00
+219%
Bull Case
$135.00
+262%
Price Range32 analysts
Low
Consensus
High
$105.00
$135.00
Current Target
Current Price
$37.33
Upside to Target
$81.67
Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.